Vera Therapeutics (VERA) Non-Current Debt (2021 - 2026)
Vera Therapeutics (VERA) posted Non-Current Debt of $75.0 million for Q1 2026, little changed on a QoQ basis from $74.8 million in Q4 2025, and up 50.06% year-over-year from $50.0 million in Q1 2025.
Vera Therapeutics (VERA) Non-Current Debt (2021 - 2026) Analysis & Trends
Vera Therapeutics' Non-Current Debt history runs 6 years deep, the most recent figure standing at $75.0 million for Q1 2026.
- Quarterly Non-Current Debt rose 50.06% year-over-year to $75.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.0 million (up 50.06% YoY) and the FY2025 annual result came in at $74.8 million, up 49.68% from the prior year.
- Non-Current Debt was $75.0 million for Q1 2026 at Vera Therapeutics, roughly flat from $74.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $75.0 million in Q1 2026 and bottomed at $5.0 million in Q3 2022.
- A 5-year average of $42.0 million and a median of $50.0 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2023 — Non-Current Debt surged 403.42% — and 2025, when it declined 0.13%.
- Vera Therapeutics' Non-Current Debt stood at $25.0 million in 2022, then surged by 99.51% to $49.9 million in 2023, then rose by 0.25% to $50.0 million in 2024, then jumped by 49.68% to $74.8 million in 2025, then increased by 0.26% to $75.0 million in 2026.
- Business Quant data shows VERA's Non-Current Debt at $75.0 million in Q1 2026, $74.8 million in Q4 2025, and $75.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | 75.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.03 Mn |
| Dec 31, 2025 | 74.84 Mn |
| Sep 30, 2025 | 75.00 Mn |
| Jun 30, 2025 | 74.46 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | 50.07 Mn |
| Dec 31, 2023 | 49.88 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 24.96 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.00 Mn |